Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 1204 - файл
.pdf
161
https://t.me/med1917
166. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal
reflux disease and related neoplasia / K.R. McQuaid, L. Laine, M.B. Fennerty, [et al.] //
Alimentary Pharmacology & Therapeutics. – 2011. – Vol. 34. – P. 146–165. DOI:
10.1111/j.1365-2036.2011.04709.x
167. Tack, J. Review article: role of pepsin and bile in gastro-oesophageal reflux disease
/ J. Tack // Alimentary Pharmacology & Therapeutics. – 2005. – Vol. 22 (Suppl. 1). – P.
48–54.
168. Tack, J. Review article: the role of bile and pepsin in the pathophysiology and
treatment of gastro-oesophageal reflux disease / J. Tack // Alimentary Pharmacology &
Therapeutics. – 2006. – Vol. 24 (Suppl 2). – P. 10–16. doi: 10.1111/j.1365-
2036.2006.03040.x.
169. TGR5 controls bile acid composition and gallbladder function to protect the liver
from bile acid overload / V. Bidault-Jourdainne, G. Merlen, M. Glénisson, [et al.] // JHEP
Reports. – 2020. – Vol. 3. – № 2. – P. 100214. doi: 10.1016/j.jhepr.2020.100214.
170. The association between cholecystectomy and gastroesophageal reflux symptoms:
a prospective controlled study / O.S. Lin, R.A. Kozarek, A. Arai, [et al.] // Annals of
Surgery. – 2010. – Vol. 251. – № 1. – P. 40-45. DOI: 10.1097/SLA.0b013e3181b9eca4.
171. The effect of cisapride in patients with reflux esophagitis: an ambulatory
esophageal manometry/pH-metry study / W.G. Paterson, H. Wang, I.T. Beck // American
Journal of Gastroenterology. – 1997. – Vol. 92. – P. 226–230.
172. The effect of famotidine on gastroesophageal and duodeno-gastro-esophageal
refluxes in critically ill patients / Y. Xin, N. Dai, L. Zhao, [et al.] // World Journal of
Gastroenterology. – 2003. – Vol. 9. – № 2. – P. 356–358. DOI: 10.3748/wjg.v9.i2.356.
173. The effects of baclofen for the treatment of gastroesophageal reflux disease: a metaanalysis of randomized controlled trials / S. Li, S. Shi, F. Chen, [et al.] // Gastroenterology
Research and Practice – 2014. – No. 307805. DOI: 10.1155/2014/307805.
174. The intrinsically disorderly story of Ki-67 / L. Remnant, N.Y. Kochanova, C. Reid,
[et al.] // Open Biology. – 2021. – Vol. 11. – № 8. – P. 210120. DOI:
10.1098/rsob.210120.
162
https://t.me/med1917
175. The microscopic anatomy of the esophagus including the individual layers,
specialized tissues, and unique components and their responses to injury / X. Zhang, D.
Patil, R.D. Odze, [et al.] // Annals of the New York Academy of Sciences. – 2018. – Vol.
1434(1). – P. 304-318. DOI: 10.1111/nyas.13705.
176. The role of an alginate suspension on pepsin and bile acids - key aggressors in the
gastric refluxate. Does this have implications for the treatment of gastro-oesophageal
reflux disease? / V. Strugala, J. Avis, I.G. Jolliffe, [et al.] // Journal of Pharmacy and
Pharmacology. – 2009. – Vol. 61. – № 8. – P. 1021–1028. DOI: 10.1211/JPP/61.08.0005.
177. Topical protection of human esophageal mucosal integrity / P. Woodland, F.
Batista-Lima, C. Lee, [et al.] // American Journal of Physiology-Gastrointestinal and
Liver Physiology. – 2015. – Vol. 308. – № 12. – P. G975–G980. DOI:
10.1152/ajpgi.00424.2014.
178. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity /
D. Nehra, P. Howell, C.P. Williams, [et al.] // Gut. – 1999. – Vol. 44. – P. 598-602.
179. Turcotte, S. Gastroesophageal reflux and cancer / S. Turcotte, A. Duranceau //
Thoracic Surgery Clinics. – 2005. – Vol. 15. – P. 341–352.
180. Vaezi, M.F. Importance of duodeno-gastro-esophageal reflux in the medical
outpatient practice / M.F. Vaezi, J.E. Richter // Hepatogastroenterology. – 1999. – Vol.
46. – № 25. – P. 40–47.
181. Vaezi, M.F. Role of Acid and Duodenogastroesophageal Reflux in
Gastroesophageal Reflux Disease / M.F. Vaezi, J.E. Richter // Gastroenterology. – 1996.
– Vol. 111. – P. 1192-1199.
182. Vandenplas, Y. Gastroesophageal Reflux in Children. / Y. Vandenplas; –
Cham:Springer, 2017. – 288 p. – ISBN 978-3-319-60678-1.
183. Wu, Y. Role of the mean nocturnal baseline impedance in identifying evidence
against pathologic reflux in patients with refractory gastroesophageal reflux disease
symptoms as classified by the Lyon Consensus / Y. Wu, Z. Guo, C. Zhang, Y. Zhan //
Journal of Neurogastroenterology and Motility. – 2022. – Vol. 28(1). – P. 121-130. DOI:
10.5056/jnm20277.
163
https://t.me/med1917
184. Yield of 24-hour esophageal pH and bilitec monitoring in patients with persisting
symptoms on PPI therapy / G. Karamanolis, T. Vanuytsel, D. Sifrim, [et al.] // Digestive
Diseases and Sciences. – 2008. – Vol. 53. – № 9. – P. 2387–2393. DOI: 10.1007/s10620007-0186-6.
Соседние файлы в папке @xirurgi_2025